Abstract
From the end of 2019 when the COVID-19 pandemic broke out in China to the end of 2022 when the Chinese government announced the removal of the containment of the pandemic situation, the 3-year-long pandemic has caused a large impact on the medical industry. Through a study on the trend of PE (price to earnings ratio) value of A shares in the medical industry and a linear regression analysis, this paper explores the impact of the COVID-19 pandemic on the medical industry as well as its correlation to the severity of the pandemic situation and Chinas pandemic prevention policy. It was found that, on the whole, the PE value of the medical industry and the industry valuation increased significantly in comparison with that before the pandemic. Although its changing pattern in the past three years has no obvious correlation with the severity of the pandemic situation in China, it is quite consistent with the three stages of China's pandemic prevention divided according to the pandemic prevention and control policies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Advances in Economics, Management and Political Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
